[HTML][HTML] Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients

…, O Vapalahti, M Lappalainen, HR Kreivi, H Jarva… - PloS one, 2021 - journals.plos.org
Background Understanding the false negative rates of SARS-CoV-2 RT-PCR testing is
pivotal for the management of the COVID-19 pandemic and it has implications for patient …

[HTML][HTML] Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial

…, IEJ Kalliala, H Ansakorpi, HR Kreivi… - Nature …, 2022 - nature.com
We report the first long-term follow-up of a randomized trial (NCT04978259) addressing the
effects of remdesivir on recovery (primary outcome) and other patient-important outcomes …

Male predominance in disease severity and mortality in a low Covid-19 epidemic and low case-fatality area–a population-based registry study

…, S Silen, E Kortela, M Ahava, HR Kreivi… - Infectious …, 2021 - Taylor & Francis
Background Men reportedly suffer from a more severe disease and higher mortality during the
global SARS-CoV-2 (Covid-19) pandemic. We analysed sex differences in a low epidemic …

[HTML][HTML] Changes in the societal burden caused by sleep apnoea in Finland from 1996 to 2018: A national registry study

…, H Hasala, HR Kreivi, H Avellan-Hietanen… - The Lancet Regional …, 2022 - thelancet.com
… However, in addition to AHI ≥5/h, the diagnosis of obstructive sleep apnoea syndrome
requires symptoms of sleep apnoea. Therefore, AHI values are not considered as clinically …

Effect of ventilation therapy on mortality rate among obesity hypoventilation syndrome and obstructive sleep apnoea patients

HR Kreivi, T Itäluoma, A Bachour - ERJ Open Research, 2020 - Eur Respiratory Soc
… PAP therapy was offered to patients with a respiratory event index (REI) of >15 h −1 during
the sleep study or patients with a REI of 5–14 h −1 and symptoms related to OSA. We started …

Successful treatment of persisting SARS-CoV-2 infection in an immunocompromised patient with repeated nirmatrelvir/ritonavir courses: a case report

AL Lindahl, MJ Ahava, M Haukipää, HR Kreivi… - Infectious …, 2023 - Taylor & Francis
Background In immunocompromised patients, persistent SARS-CoV-2 viral shedding and
relapsing COVID-19 pneumonia have been described. Currently, little is known about the …

[HTML][HTML] Lung function and exercise capacity 6 months after hospital discharge for critical COVID-19

…, P Piirilä, P Kauppi, J Paajanen, HR Kreivi… - BMC Pulmonary …, 2022 - Springer
Background The significant morbidity caused by COVID-19 necessitates further understanding
of long-term recovery. Our aim was to evaluate long-term lung function, exercise capacity, …

Frequency of upper airway symptoms before and during continuous positive airway pressure treatment in patients with obstructive sleep apnea syndrome

HR Kreivi, P Virkkula, J Lehto, P Brander - Respiration, 2010 - karger.com
… usage of 1 4 h per night for 1 70% of days [32–34], which equates to an average use of 2.8
h/ night. Of our patients, 58% used the device for 1 4 h/night and 68% for 6 2.8 h/night. These …

[HTML][HTML] The prevalence of non-invasive ventilation and long-term oxygen treatment in Helsinki University Hospital area, Finland

P Kotanen, P Brander, HR Kreivi - BMC Pulmonary Medicine, 2022 - Springer
Background Chronic respiratory failure (CRF) can be treated at home with non-invasive
ventilation (NIV) and/or long-term oxygen (LTOT). The prevalence of these treatments is largely …

Willingness score obtained after a short CPAP trial predicts CPAP use at 1 year

HR Kreivi, P Maasilta, A Bachour - Sleep and Breathing, 2014 - Springer
… The percent nights used >4 h: number of nights when CPAP was used more than 4 h … ± 2.4
h/day at 3 months calculated over the whole 3-month period, and mean ± SD 4.1 ± 2.3 h and …